Martin Huber
Overview
Martin Huber received $3M in total compensation, including $194K in salary, at Mersana Therapeutics in 2023. Martin Huber also received an average of $2M at Xilio Therapeutics from 2020 to 2023.
- 2023
- 2022
- 2021
- 2020
Xilio TherapeuticsFormer President and Head of R&D
Mersana TherapeuticsPresident and Chief Executive Officer
Xilio TherapeuticsPresident and Head of R&D
Xilio TherapeuticsPresident of R&D and Chief Medical Officer
Xilio TherapeuticsPresident of R&D and Chief Medical Officer
Source: SEC filings on April 25, 2024, April 26, 2024, April 25, 2023, and April 26, 2022.
Related executives
We found 15 more executives who work or worked at Mersana Therapeutics and Xilio Therapeutics.
Anna Protopapas
Mersana Therapeutics
Chief Executive Officer
René Russo
Xilio Therapeutics
Chief Executive Officer
Arvin Yang
Mersana Therapeutics
Chief Medical Officer
Christopher Frankenfield
Xilio Therapeutics
Chief Operating Officer
Brian DeSchuytner
Mersana Therapeutics
Chief Financial Officer
Timothy Lowinger
Mersana Therapeutics
Senior Vice President, Chief Science and Technology Officer
Alejandra Carvajal
Mersana Therapeutics
Chief Legal Officer
Mohan Bala
Mersana Therapeutics
Senior Vice President, Chief Development Officer
News
Mersana Therapeutics CEO Anna Protopapas' 2023 pay jumps 56% to $4.5M
April 26, 2024
Xilio Therapeutics CEO René Russo's 2023 pay jumps 36% to $3M
April 25, 2024
Xilio Therapeutics CEO René Russo's 2022 pay falls 60% to $2.2M
April 25, 2023
Xilio Therapeutics CEO René Russo's 2021 pay jumps 118% to $5.5M
April 26, 2022